Individuals with Type 2 diabetes can utilize various digital health tools, such as mobile apps for iPhones and remote patient monitoring devices, to effectively regulate their blood glycemic levels. Using a glucometer at home, patients can transmit their test data to their healthcare team through an app, web portal, phone call, or scheduled appointment.
Glucose monitors and insulin pumps not beneficial for type 2 diabetes patients
Stanford Medicine researchers have developed a voice-based artificial intelligence application for a widely used “smart speaker.” This innovative tool provides patients with accurate insulin dosage information without the need for technical or mathematical proficiency. Unlike existing monitoring tools, this app eliminates the necessity for direct contact with a healthcare professional, offering a convenient and accessible solution for patients.
Dr. Ashwin Nayak, a clinical assistant professor of medicine, emphasized the limited access to care for individuals. The study, published in JAMA Network Open, promotes patient empowerment.
In a randomized trial, participants using the system achieved faster optimal blood glucose levels and better adherence to prescribed insulin doses compared to the control group. Additionally, they reported reduced emotional distress associated with diabetes.
Patients with type 2 diabetes typically do not find glucose monitors or insulin pumps, commonly employed by those with type 1 diabetes, to be beneficial. Unlike type 1 diabetes, where insulin pumps address insulin deficiency by supplying a constant amount of insulin, type 2 diabetes involves insulin resistance. As a result, the insulin requirements of type 2 diabetics are often less consistent.
The study involving 32 individuals with type 2 diabetes, all using insulin, aimed to improve blood glucose control. Half received a speaker with voice-based AI software. The software stored individual insulin protocols and participants checked in daily with the phrase “Check in with clinical trial,” sharing clinical data like recent insulin use and fasting blood glucose readings.
In the study, participants using the app achieved better diabetes control (81%) compared to those with traditional care (25%). The voice-activated device shows potential for enhancing access and convenience, particularly for older patients with type 2 diabetes.